You are here: Industry Insights > nasal

News List

Proprietary Nasal Delivery Formulation of Diazepam Developed by Particle Sciences Reaches NDA contractpharma
November 12, 2018
Proprietary Nasal Delivery Formulation of Diazepam Developed by Particle Sciences Reaches NDA
Product Quest Manufacturing Recalls All Nasal Products, Baby Oral Gels americanpharmaceuticalreview
September 03, 2018
Product Quest Manufacturing has announced a voluntary recall of Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist due to a finding of microbial contamination identified as Pseudomonas aeruginosa.
Marinomed effectively tests new combination drug against VRTI biospectrumasia
July 19, 2018
A comprehensive series of tests conducted by Marinomed suggest that these can be effectively treated using a combination of Carragelose for its efficacy against cold viruses, and Xylometazoline a well-known drug that targets inflamed nasal mucous membrane
Therapix signs license with Yissum for cannabinoid nasal drug delivery technology europeanpharmaceuticalreview
April 11, 2017
Therapix Biosciences, a specialty clinical-stage pharmaceutical company specialising in the development of cannabinoid-based drugs, has signed a sublicense agreement for Yissum Research Development Company of the Hebrew University nasal drug delivery tech

Previous page 1 2 Next page